National Registry and Cohort Study of Pulmonary Vascular Disease
Nanjing First Hospital, Nanjing Medical University
1,000 participants
Mar 29, 2022
OBSERVATIONAL
Conditions
Summary
This is a observational、multicenter, prospective cohort study for patients with pulmonary hypertension (PH). The purposes of this study were to evaluate the etiology、clinical characteristics、treatment modalities, and outcomes of patients with PH；also to set up registration system of PH in China, to build a database of Chinese PH, to establish a web-based international standard data acquisition system for PH and a multicenter clinical research platform. The results of the study will provide a basis for the future national health policy for prevention and treatment of PH.
Eligibility
Inclusion Criteria2
- Newly diagnosed or previously diagnosed patients with PH.
- Documentation of mean pulmonary arterial pressure (mPAP) \>20 mm Hg by right heart catheterization, performed at any time prior to study enrollment.
Exclusion Criteria2
- Have not had documentation of hemodynamic criteria for PH by right heart catheterization at some time preceding study entry and following development of symptoms associated with PH.
- Do not meet the required hemodynamic criteria for entry into the study.
Interventions
The clinical course and disease management of pulmonary hypertension patients
Locations(13)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05368467